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Apoptosis-inducing natural products found in utero during
murine pregnancy
Stephen D Liberles and Stuart L Schreiber
Background: Hormones, lipids, vitamins and other biologically active small
molecules can be removed from animal tissues by extraction with organic
solvents. These compounds can have dramatic effects on cultured cells and the
characterization of such compounds can lead to the discovery of new functions
for known molecules, or even to the discovery of previously unknown compounds.
Results: Organic-soluble compounds in 17.5-day-old mouse embryos were
removed with tert-butylmethylether and found to induce apoptosis in T-antigen-
transformed Jurkat T cells. These embryonic extracts were fractionated and their
apoptosis-inducing components were identified as a mixture of polyunsaturated
fatty acids, including arachidonic, docosatetraenoic and docosahexaenoic
acids. Docosatetraenoic acid was the most potent apoptosis inducer with an
effective dose (ED50) of 30 µM. 
Conclusions: A family of polyunsaturated fatty acids is shown to be abundant
in utero during pregnancy. Members of this family are able to induce cleavage
of poly(ADP)ribose polymerase, and ultimately to induce apoptosis, in
T-antigen-transformed Jurkat T cells. Free radical scavengers, including phenol
and benzyl alcohol, block the apoptosis-inducing properties of these
polyunsaturated fatty acids; this is consistent with a lipid peroxidation
mechanism involving formation of hydroperoxy fatty acids.
Introduction
While studying the actions of small-molecule dimerizers,
we measured the tissue distribution of rapamycin follow-
ing its injection into transgenic mice. We removed various
mouse tissues and extracted them with organic solvent.
The presence of rapamycin in these tissue extracts was
determined by monitoring their effects on cells engi-
neered to have a transcriptional response to rapamycin
[1–3]. We were surprised to observe that the organic
extracts of embryos removed from uninjected pregnant
mice were able to induce apoptosis in T-antigen-trans-
formed Jurkat T cells (hereafter referred to as TAg Jurkat
T cells [2]). The organic extracts of mouse embryos
contain a large number of structurally interesting and bio-
logically active compounds and we sought to identify the
active apoptosis-inducing component in this mixture. 
The concept of studying the molecules that compose
animal tissue dates back to the earliest stages of bio-
chemistry research. The isolation of urea from urine by
Hermann Boerhavve (1668–1738) and later the synthesis
of urea by Friedrich Wohler (in 1828) provided the first
well-documented studies of a compound derived from
living tissue, thus proving the notion that living systems
were tractable to scientific investigation [4]. These
results initiated a cascade of research probing the compo-
sition of animal tissue, and thus effective procedures
were developed to remove and purify compounds such as
fatty acids, carbohydrates, peptides, and later DNA [4]. 
As more was learned about the components of animal
tissue, many natural product and synthetic chemists moved
away from the study of animal-based small molecules.
Instead, they shifted towards the study of small molecules
derived from alternative sources, such as microbes, plants
and marine organisms, that alter the normal function of
animal tissue. Our understanding of biological systems has
evolved since the initial isolation of animal-derived small
molecules, however, and tissue extracts can now be
screened for novel activities that were not previously
known or understood at a molecular level. In this study, we
describe the production of a natural product mixture from
mouse embryonic tissue. Compounds in these embryonic
extracts have effects on cells in culture and we report the
purification and structural characterization of animal com-
pounds that induce apoptosis in TAg Jurkat T cells.
Results
Induction of apoptosis by crude organic extracts of mouse
embryonic tissue 
Several tissues, including the uterine segment consisting
of both maternal and embryonic tissue, were removed
from 17.5 days post-coitum pregnant mice. The dissected
tissues were incubated overnight in proteinase K buffer
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and extracted with tert-butylmethylether. The organic
layers were then dried, washed and resuspended in
ethanol to prepare them for tissue culture experiments.
The organic extracts of a number of tissues, including
uterine, brain, and liver tissue, can kill TAg Jurkat T cells;
this was initially observed by the inhibition of a constitu-
tively expressed enzymatic reporter, secreted alkaline
phosphatase (SEAP). The organic extracts of mouse
embryos were found to be the most potent. Incubation of
1 ml of TAg Jurkat T cells (1 × 106 cells/ml) with 2–5 µl of
embryonic extracts, representing the organic compounds
from about 100 µl of embryonic tissue, is sufficient to
induce cell death (Figure 1a). 
To test whether the organic extracts of mouse embry-
onic tissue induce apoptosis, we examined whether
poly(ADP)ribose polymerase (PARP) is cleaved after
treatment with extract. PARP is a DNA repair enzyme
that is rapidly cleaved during apoptosis, presumably so
that it cannot counteract the nucleases that ultimately kill
the cells [5]. Conversion of PARP from the full-length
116 kDa protein to the inactive 85 kDa fragment is
observed within 5 hours of treatment with embryonic
extracts (Figure 1b). The minimal amount of embryonic
extracts required to induce PARP cleavage is close to the
IC50 for SEAP inhibition. At higher concentrations of
embryo extracts, neither full-length PARP nor the 85 kDa
cleavage product could be detected, perhaps because at
these high concentrations a constituent of embryo extracts
induces necrotic, rather than apoptotic, cell death.
Purification of the apoptotic activity from mouse embryos
A two-step purification process was used to isolate the
substance having apoptotic activity from mouse embryos.
During the first step the organic extracts from two to three
litters of embryos (corresponding to about 20–30 mouse
embryos) were separated on silica gel using a solvent gra-
dient of increasing polarity. The active fractions eluted off
the column slowly with 25% ethyl acetate/hexane, and all
subsequent columns were run using only this solvent
mixture as the mobile phase. The diversity of compounds
in the embryonic extracts can be seen on a thin-layer chro-
matogram of the silica gel column fractions (Figure 2a).
Fractions with apoptotic activity were pooled. 
Analysis of the pooled active fractions by mass spectrom-
etry (Figure 2b) revealed a family of co-migrating mol-
ecules. Two trends were observed in this mass spectrum.
First, the major compound peaks differed from each
other by 22–28 atomic mass units, where 28 is the mol-
ecular weight of an ethylene (–CH2CH2–) unit. Second,
each major compound peak was surrounded by minor
compound peaks that differed in mass by exactly two or
multiples of two, thus suggesting the presence or
absence of double bonds. An explanation for these obser-
vations is shown in Figure 2c. A second family of peaks
was also observed in the higher mass end of the spec-
trum. These peaks could correspond to dimers of the
lower molecular-weight peaks, or to an entirely different
family of molecules.
As a number of compounds co-migrated on the silica-gel
column, a second purification step was required to isolate
the active compounds. Recycling high performance liquid
chromatography (recycling HPLC), using columns that
resolve compounds by size and polarity, separated the
mixture further and the apoptosis-inducing activity co-
migrated with one of two closely running fractions. The
mass spectra of these fractions (Figure 3a) suggested
improved purity as only a subset of the original peaks was
present in each fraction. The results also suggested that
the higher molecular-weight peaks correspond to dimers
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Figure 1
Induction of apoptosis by crude embryonic extracts. (a) Inhibition of a
constitutive reporter gene, secreted alkaline phosphatase (SEAP), by
embryonic extracts. TAg Jurkat T cells were transfected with a plasmid
containing a SEAP reporter construct under control of the nuclear factor
of activated T cells (NFAT) enhancer. These cells were then incubated
simultaneously with phorbol myristate acetate (PMA), ionomycin and
various concentrations of embryonic extracts. After 24 h, SEAP activity
was determined as described in the Materials and methods section.
(b) Poly(ADP)ribose polymerase (PARP) cleavage by embryonic
extracts. Wild-type TAg Jurkat T cells were incubated with various
concentrations of embryonic extracts for 5 h. Samples were lysed and
analyzed by western blot using an antibody that recognizes PARP.
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of the lower molecular-weight species. An IR spectrum
was obtained for each of these fractions (data not shown).
The data demonstrated that the compounds are both
similar and structurally simple. All of the compounds
contain only one stretch in the carbonyl region of the spec-
trum; the only interpretable difference between the IR
spectra of these compounds is the amplitude of the stretch
at 3010 wave numbers, suggesting a difference in the
number of double bonds in these molecules. One inactive
peak, corresponding to a molecular weight of 282, was
remarkably pure. Structural characterization of the com-
pound in this purest fraction, although it was inactive,
would provide structural information about the closely
migrating active peak. 
Analysis of this compound by gas chromatography and
mass spectrometry (GC/MS) led to its identification as
oleic acid, based on its fragmentation pattern in the mass
spectrum. Likewise, the IR spectrum of oleic acid
matched identically with this compound (Figure 3b).
Because the other three compounds differ from oleic acid
only by the number of carbons and double bonds, as sug-
gested by both MS and IR, we assigned the other three
peaks as arachidonic, docosatetraenoic and docosa-
hexaenoic acids. The structures of these compounds are
shown in Figure 3c.
Effects of authentic polyunsaturated fatty acids on TAg
Jurkat T cells
To verify that these polyunsaturated fatty acids are indeed
the apoptosis-inducing molecules from mouse embryos,
authentic samples of arachidonic, docosahexaenoic and
docosatetraenoic acids were obtained and compared in the
apoptosis assays. All three polyunsaturated fatty acids
were found to be toxic to TAg Jurkat T cells, as deter-
mined by inhibition of the activity of a constitutive
reporter gene product (Figure 4a). Both arachidonic and
docosahexaenoic are similarly potent, with an ED50 of
about 70 µM; docosatetraenoic acid is slightly more potent
with an ED50 of 30 µM.
The polyunsaturated fatty acids also induce cleavage of
PARP, with docosatetraenoic acid being active at the
lowest concentration, between 30–70 µM (Figure 4b).
The minimal concentrations of docosahexaenoic acid and
arachidonic acid required to cleave PARP are 70–100 µM
and 200 µM, respectively. Incubating cells with about
300 µM concentration of any of the fatty acids results in
the complete disappearance of full-length or cleaved
PARP as judged by western blot analysis, a result similar
to that induced by high concentrations of crude
embryo extracts.
On the basis of these inhibitory constants, we can esti-
mate the concentration at which these compounds exist
in the mouse embryo. Extraction of the organic-soluble
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Figure 2
Partial purification of the apoptosis-inducing constituent by silica gel
chromatography. (a) Thin-layer chromatogram of compounds from
mouse embryos. The components of mouse embryo extracts were
fractionated on silica gel and a thin-layer chromatogram was
performed on the fractions using 50% ethyl acetate/hexane as a
mobile phase. Those fractions with apoptotic activity are indicated.
(b) Mass spectrum of silica-gel-purified embryonic extracts. The active
fractions shown in (a) were pooled and mass spectrometry was
performed on an aliquot of the pooled fractions. In the mass
spectrum, two families of peaks were observed, and the members of
each family differed in mass by 22–28 atomic mass units.
Furthermore, each peak was surrounded by minor peaks that differed
in mass by two or multiples of two. (c) An explanation for how two
structurally similar compounds could differ in mass by 24, 26 or 28
atomic mass units.
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constituents of about 200 µl of embryonic tissue provides
the minimal amount sufficient to induce apoptosis in 1 ml
of TAg Jurkat T cells. As the IC50 for apoptosis by these
polyunsaturated fatty acids is between 30 and 100 µM, the
original concentration is ~150–500 µM in mouse embryos,
assuming complete recovery of these compounds during
the extraction process. This calculation also assumes that
all of the apoptotic activity in the extracts is due to the
polyunsaturated fatty acids. During the silica-gel fraction-
ation, a second minor peak of apoptotic activity elutes
368 Chemistry & Biology 2000, Vol 7 No 5
Figure 3
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Structural determination of the active apoptosis-inducing constituent.
(a) Mass spectra of two closely migrating JAI peaks. The pooled silica-
gel-purified material was injected on the JAI recycling HPLC. The
fraction displaying apoptotic activity had only a subset of the
compounds found in the pre-JAI-purified material. Furthermore, a closely
migrating inactive compound was pure. (b) Comparison of the inactive
peak to oleic acid using infrared (IR) spectroscopy. After gas
chromatography and mass spectrometry (GC/MS) identified the
inactive peak as oleic acid, this assignment was confirmed by
comparison of the IR spectra of these compounds. As the IR spectra
matched closely, we judged the 282 molecular-weight peak to be oleic
acid. (c) Structures of the mouse embryonic lipids found in the active
fraction of the JAI-purified material.
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under more polar solvent conditions, but this peak pro-
vides only a small percentage of the total apoptotic activity
from the crude extracts.
Anti-oxidants block fatty-acid-induced PARP cleavage
To probe the mechanism of apoptosis induced by these
polyunsaturated fatty acids, we tested whether lipoxyge-
nase inhibitors (30 µM nordihydroguaiaretic acid [NDGA]
or 1 mM esculetin) or cyclooxygenase inhibitors (1 mM
aspirin or 50 µM indomethacin) could block PARP cleavage
and SEAP inhibition induced by polyunsaturated fatty
acids. None of these compounds suppresses the effects of
polyunsaturated fatty acids in either assay. We then tested a
panel of presumed anti-oxidants for inhibition of PARP
cleavage as a number of such compounds, most notably
phenol and benzyl alcohol, can block tumor necrosis factor
(TNF)-induced apoptosis in L929 cells [6]. Some anti-oxi-
dants have no effect, such as 50 µM vitamin E, whereas
others, including phenol and benzyl alcohol, do cause the
inhibition of docosatetraenoic-acid-induced PARP cleavage
(Figure 5). The minimal concentration of phenol or benzyl
alcohol required to block PARP cleavage induced by
100 µM docosatetraenoic acid is 0.3%, about a 300-fold
molar excess. Other anti-oxidants tested, 1% dimethyl sul-
foxide (DMSO) and 1.2 mM cysteine, also partially blocked
polyunsaturated-fatty-acid-induced PARP cleavage (data
not shown). One interpretation of these results is that the
mechanism of polyunsaturated fatty-acid-induced PARP
cleavage in TAg Jurkat T cells involves oxidation of the
lipids, perhaps by reactive oxygen species found in these
cells, although the mechanism of phenol and benzyl alcohol
protection is yet to be elucidated.
Discussion
Arachidonic, docosatetraenoic and docosahexaenoic acids
are members of a well-known family of polyunsaturated
fatty acids. These compounds were isolated from mouse
embryonic tissue based on their ability to induce apoptosis
in TAg Jurkat T cells. Pure samples of these compounds
induce apoptosis at concentrations between 30 and
100 µM, whereas their concentration in living embryos
appears to be higher, based on the amount of crude
organic extract required to induce apoptosis. These fatty
acids have been shown previously to have effects on many
cell lines, including the ability to induce apoptosis, and
their presence in utero prior to birth is important for the
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Figure 4
Authentic polyunsaturated fatty acids induce apoptosis in TAg Jurkat
T cells. (a) Inhibition of SEAP activity by authentic samples of
unsaturated fatty acids. TAg Jurkat T cells were transfected with NFAT-
SEAP, and treated simultaneously with PMA, ionomycin and various
concentrations of fatty acids, as indicated. After 24 h, SEAP assays
were performed as described in the Materials and methods section.
(b) Cleavage of PARP induced by polyunsaturated fatty acids. TAg
Jurkat T cells were incubated for 5 h with the indicated concentrations
of polyunsaturated fatty acids. DTA, docosatetraenoic acid; DHA,
docosahexaenoic acid; AA, arachidonic acid. Cleavage of PARP was
determined by western blot analysis.
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Figure 5
Suppression of docosatetraenoic-acid-induced PARP cleavage by
phenol and benzyl alcohol. TAg Jurkat T cells were incubated with the
indicated concentrations of (a) phenol and (b) benzyl alcohol for 10 min
and then incubated either alone or with 100 µM docosatetraenoic acid
for 5 h. Cleavage of PARP was monitored by western blot analysis.
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pregnancy process and proper embryo development, as
shown by deprivation experiments.
Direct addition of these polyunsaturated fatty acids to
several cell lines, particularly cancer cell lines [7], can
induce apoptosis. For example, polyunsaturated fatty
acids can induce apoptosis in pancreatic B-cell lines at a
concentration of 1 mM and have been implicated as the
causative agent of non-insulin-dependent diabetes melli-
tus as a result of their apoptosis-inducing properties [8].
Furthermore, many apoptotic stimuli elicit the controlled
release of arachidonic acid, including TNF, a cytokine
that was initially identified by its ability to inhibit the pro-
liferation of cancerous tissues. Treatment of L929 cells
with TNF leads to phospholipase A2 activation [9,10] and
arachidonic acid release [11,12], and blocking phospholi-
pase A2 activation mitigates the toxicity of TNF [6].
Arachidonic acid has also been implicated in the apoptosis
of B and T cells during lymphocyte maturation [13]. Phos-
pholipase A2 can be activated by stimulation of antigen
receptors in immature B and T cells, where antigen recep-
tor stimulation leads to apoptosis. In contrast, phospholi-
pase A2 is not expressed and arachidonic acid is not
released during the activation of mature lymphocytes [13].
These results demonstrate a correlation between the pres-
ence and absence of arachidonic acid with a change in the
phenotypic outcome of antigen receptor stimulation from
a decision to live to a decision to die.
The ability of polyunsaturated fatty acids to induce apop-
tosis might depend on the presence of reactive oxygen
species in the cell [14,15]. Reactive oxygen species, gener-
ated in the mitochondria of cells undergoing apoptosis,
can initiate a catalytic peroxidation of polyunsaturated
lipids [14]. The resulting hydroperoxy fatty acids can
induce apoptosis directly in many cell lines [16]. Cells that
are normally resistant to polyunsaturated fatty acids can be
rendered sensitive to them by expression of a cytochrome
that increases intracellular levels of reactive oxygen
species [17]. Furthermore, several anti-apoptotic agents
reduce the cellular concentration of reactive oxygen
species. Bcl-2 is an anti-apoptotic gene product that is
localized to the generation sites of radical oxygen species,
such as the mitochondria [18]. Overexpression of Bcl-2
lowers the levels of hydroperoxy fatty acids generated fol-
lowing apoptotic stimuli and blocks cell death normally
induced by oxidative stress [18]. Oxygen radical scav-
engers, such as phenol and benzyl alcohol, that can reduce
the levels of reactive oxygen species and block TNF-
induced cytotoxicity in L929 cells [6] can also block
polyunsaturated-fatty-acid-induced apoptosis in TAg
Jurkat T cells. One mechanism that is consistent with
these observations is that polyunsaturated fatty acids
when administered to TAg Jurkat T cells react with a cat-
alytic amount of radical oxygen species to form hydroper-
oxy fatty acids that promote the death of the cells.
Whether polyunsaturated fatty acids undergo similar
radical-mediated reactions under physiologically relevant
conditions in living embryos is unclear.
The high concentration of the unsaturated fatty acids
described in this study in embryonic tissue is known to be
essential for proper development. A critical role for
polyunsaturated fatty acids in embryos is suggested by a
mouse engineered to be deficient in phospholipase A2 by
gene deletion [19,20]. Male phospholipase A2 ‘knockout’
mice develop and reproduce normally, but female knock-
out mice are infertile, and almost all of their offspring die
before birth. Deficiency of an arachidonic acid metabolite,
prostaglandin F2α, is proposed to explain the failure of the
pregnancy process [19,21] and perhaps the high concentra-
tion of polyunsaturated fatty acids we observe in utero
serves as a reservoir for the synthesis of such key metabo-
lites during pregnancy.
Important roles for fatty acids in early development and
pregnancy have also been suggested by dietary studies. As
mice and humans cannot make highly unsaturated fatty
acids de novo [22], they must be made available through
their diet; depriving mice of these essential fatty acids has
highlighted some of the roles of these lipids in living
animals. From such studies, significant amounts of docosa-
hexaenoic acid are required for proper development of the
central nervous system and retina [23]. The primary
source of docosahexaenoic acid is from either the direct
uptake of the lipid itself or from a biosynthetic precursor,
linolenic acid, which can be converted into docosa-
hexaenoic acid in vivo [22]. Pregnant mice fed a diet defi-
cient in linolenic and docosahexaenoic acids give birth to
offspring that have impaired visual and learning activity.
In humans, these effects are seen in premature infants fed
similar diets [23]. Supplementing sufficient quantities of
docosahexaenoic acid into the diet of premature infants is
now realized to ensure proper visual and cognitive devel-
opment of human infants [23].
Other fatty acids, including linoleic and arachidonic acids,
are also required in the diet at early stages of life [22], and
mice deprived of these fatty acids display a number of
defects including stunted growth. Human infants born
preterm have diminished growth rates for at least a year
compared to infants born at term, and this problem can be
mitigated by arachidonic acid supplementation [24]. Thus,
it is generally appreciated that sufficient levels of arachi-
donic acid and docosahexaenoic acid are important in the
diet at early stages of life, but the developmental role, if
any, of docosatetraenoic acid, the most potent apoptosis-
inducer isolated in this study, remains unclear.
Significance
We report that the organic extracts of mouse embryos
induce apoptosis in T-antigen-transformed (TAg) Jurkat
370 Chemistry & Biology 2000, Vol 7 No 5
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T cells. Purification and structural characterization of
the active components identified them as a family of
polyunsaturated fatty acids, including docosatetraenoic
acid, docosahexaenoic acid and arachidonic acid. The
apoptosis-inducing properties of these polyunsaturated
fatty acids were verified using authentic samples of the
compounds. Furthermore, they were sensitive to free-
radical inhibitors, consistent with a mechanism involv-
ing catalytic lipid peroxidation by reactive oxygen
species. The abundance of these compounds in utero
prior to birth is consistent with the proposed roles of
these compounds in the pregnancy process and in early
embryo development. Furthermore, the ability of these
compounds to induce apoptosis has been implicated in
both disease processes, such as non-insulin-dependent
diabetes mellitus and ethanol-induced liver toxicity [17],
and fundamental natural processes, such as lymphocyte
maturation and the antiproliferative effects of tumor
necrosis factor (TNF). Further research will clarify
both the roles these compounds play in pregnant
mothers and developing embryos, and the physiological
significance of the apoptosis-inducing properties of these
polyunsaturated fatty acids.
Materials and methods
Tissue culture
TAg Jurkat T cells were purchased from American type culture collec-
tion (ATCC) and maintained in RPMI media supplemented with 10%
fetal calf serum, 1% penicillin/streptomycin and 1% glutamine. TAg
Jurkat T cells were obtained and grown as previously described [2].
Arachidonic, docosatetraenoic and docosahexaenoic acids were pur-
chased from Sigma. IR spectra were obtained on a Galaxy Series FTIR
3000 and GC/MS data were obtained using Hewlatt Packard instru-
mentation. Mass spectra were obtained with a JEOL SX-102 by nega-
tive ion, fast atom bombardment using glycerol as the matrix.
Preparation of embryo extracts
One litter of 17.5-day-old mouse embryos, including maternal uterine
tissue, was removed and incubated in proteinase K buffer overnight
at 55°C. (Proteinase K buffer: 100 mM Tris pH 8.5, 5 mM EDTA,
0.2% SDS, 200 mM NaCl and 100 µg/ml proteinase K.) The
samples were extracted twice with 5 ml tert-butylmethylether, vor-
texed and centrifuged at 2600 rpm. The organic layers were
removed and dried under a nitrogen stream. The resulting residue
was extracted twice with 500 µl ethanol and the ethanol suspen-
sions were transferred to an Eppendorf tube and centrifuged (1 min,
14,000 rpm) to remove ethanol-insoluble material. The ethanol-
soluble portion was dried under vacuum. A pellet of about 100 µl
was typically obtained from one litter of mouse embryos. These
pellets were frozen, and later dissolved in a final volume of 200 µl
ethanol for cell-based experiments. 
PARP cleavage assays
1 ml TAg Jurkat T cells (1 × 106) were placed in a six-well plate and
exposed to a variety of conditions including crude organic extracts or
pure lipids for 5 h. The cells were transferred to a 1.5 ml Eppendorf
tube and pelleted by centrifugation (1 min, 5000 rpm). The supernatant
was discarded and the cells were lysed in 40 µl lysis buffer (10 mM
Hepes (pH 7.4), 2 mM EDTA, 0.1% CHAPS, 5 mM DTT, 1 mM PMSF,
10 µg/ml pepstatin, 10 µg/ml aprotinin, and 20 µg/ml leupeptin). After
addition of 20 µl 6× sample buffer, the samples were boiled, sonicated,
and pelleted (14,000 rpm, 1 min) prior to loading on a 6% SDS poly-
acrylamide gel. The gels were transferred to Immobilon P and PARP
protein was detected by western blot analysis using C2-10 primary
antibody to PARP (Clontech), sheep anti-mouse secondary antibody
conjugated to horseradish peroxidase (HRP; Amersham) and chemilu-
minescent detection of HRP (Amersham).
Transcription assays
A derivative of the TAg Jurkat T cell line which expresses T-antigen was
used for transcription experiments (TAg Jurkat T cells). TAg Jurkat 
T cells (1 × 107) were transfected with 1 µg of a reporter construct harbor-
ing SEAP under control of the NFAT enhancer. After transfection, these
cells were resuspended in about 4 ml tissue culture media, and treated
with 2 µg/ml PMA and 1 µg/ml ionomycin, to initiate production of SEAP.
100 µl aliquots of these cells were then exposed to different conditions,
such as pure lipids, crude organic extracts, or compounds in various
column fractions. After 24 h, SEAP activity was detected as described
previously [2]. These assays were used to screen many column fractions
quickly for the presence of apoptosis-inducing compounds.
Column chromatography
The organic extracts of two to three litters of mouse embryos were dis-
solved in a minimal volume of ethyl acetate. These extracts were loaded
on a silica-gel column and eluted with 25% ethyl acetate/hexane. With
a fraction size approximately one to two times the amount of silica gel
used, the active compounds usually eluted between the fifth and fif-
teenth fractions collected. The fractions were dried under a nitrogen
stream, resuspended in 20 µl ethanol, and tested for their ability to
induce apoptosis in TAg Jurkat T cells.
The active compounds purified on silica gel were further purified on a
recycling HPLC (JAI) using two tandem JAIGEL GS-310 columns. The
active silica-gel purified fractions were pooled, dissolved in chloroform,
and injected on the JAI HPLC. After one cycle on the JAI HPLC, many
of the compounds in the mixture displayed overlapping elution profiles,
with the active compounds having slightly faster retention times than
average. The compounds with retention times similar to the active com-
pounds were left to recycle on the JAI HPLC. After four cycles, several
fractions of the recycled material were collected and their constituents
analyzed by MS, IR and GC/MS, as described in the Results section.
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